ACADNasdaq GS

ACADIA Pharmaceuticals Inc.

30.57+3.10%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierB
Alert levelBaseline

Tier and alert level are a summary. Unlock ACAD to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+1.29%, upReturn · 1w
+20.40%, upReturn · 1m
+44.27%, upReturn · 3m
+20.73%, upReturn · 1y
−1.26%, near its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

Price is trading above its key moving averages and momentum readings are contained: the mid-term picture reads as an orderly uptrend. RSI is currently 68.

RSI (14)67.86, favorable readingUpper-neutral
MACD / signal1.15 / 1.13, favorable readingAbove signal line
SMA 5026.21, favorable readingPrice above
SMA 20024.24, favorable readingPrice above
EMA 2028.60, favorable readingPrice above
ADX (14)42.42Trending
+DI / −DI38.61 / 16.78, favorable reading+DI leading
ATR (14)0.953.1% of price — typical daily swing
Stochastic %K87.25, flagged readingOverbought zone
Bollinger bands (20)25.59 – 31.51Inside bands
ROC (10)3.94, favorable readingPositive over 10 sessions
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking ACAD reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock ACAD: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Earnings

When does ACADIA Pharmaceuticals Inc. report earnings?

ACADIA Pharmaceuticals Inc. (ACAD) is scheduled to report earnings on Nov 4, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Aug 26, 2026

See who else reports soon
Need the raw data?Get ACAD + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock ACAD